Genco

Gensco Pharma is a specialty pharmaceutical company focused on the development and commercialization of innovative drug delivery systems, particularly in the areas of transdermal and topical therapeutics. The company's proprietary MDose™ technology provides a metered-dose applicator for precise and consistent topical medication delivery, addressing the inaccuracies of traditional tubes and jars. Gensco's portfolio includes a range of branded prescription products for pain management and skin conditions, such as LidoDose and various transdermal gels. Recently, the company expanded its focus into the migraine market through the acquisition and planned launch of RizaFilm®, an oral dissolvable film formulation of rizatriptan. Gensco Pharma operates as a fully integrated pharmaceutical manufacturer with a focus on improving patient outcomes through superior quality medications and unique delivery platforms.